Most Read Articles
12 Jun 2018
Percutaneous coronary intervention (PCI) is a safe procedure to perform on obese and morbidly obese patients, a recent study has shown.
Roshini Claire Anthony, 11 Jun 2018

Patients who received a combination of ticagrelor plus aspirin within 24 hours of undergoing coronary artery bypass grafting (CABG) had significantly improved saphenous vein graft patency rates 1 year post-procedure compared with those who only received aspirin, according to findings of the DACAB* trial.

4 days ago
Higher activity of plasma xanthine oxidase appears to be linked to insulin resistance and liver dysfunction among type 2 diabetes mellitus (T2DM) patients with metabolic syndrome (MetS), according to a recent Japan study.
4 days ago
Use of quetiapine among critically ill patients rarely leads to corrected QT (QTc) interval prolongation, reports a new study.

Hypertensive disorders of pregnancies not a risk factor for kidney function decline

14 Jan 2018

Hypertensive disorders of pregnancies (HDPs) do not appear to contribute to an increase in the incidence of chronic kidney disease (CKD), according to a study.

Researchers performed a subanalysis of the Prevention of Renal and Vascular End-stage Disease (PREVEND) study, a Dutch population-based cohort with follow-up of five visits spaced about 3 years apart. The analysis included 977 women with self-reported HDPs and 1,805 women without the maternal hypertensive disorder. The mean age at baseline was 50 years in the entire cohort.

Outcomes investigated included the incidence of CKD and the course of kidney function (estimated glomerular filtration rate [eGFR] and 24-hour albuminuria) over five visits. Analysis were performed using Cox regression and generalized estimating equation analysis adjusted for age, mean arterial pressure and renin-angiotensin system (RAS) blockade.

During a median follow-up of 11 years, none of the women developed end-stage renal disease. The incidence of CKD did not significantly differ between the HDP and non-HDP groups (hazard ratio [HR], 1.04; 95 percent CI, 0.79–1.37; p=0.8). Of note was the increased use of RAS blockade following HDP at all visits.

There was a marked decrease in estimated glomerular filtration rate (eGFR) observed in both groups, with the decline being greater in the HDP group (98 to 88 vs 99 to 91 mL/min/1.73 m2; pgroup<0.01;  pgroup*visit<0.05). The group effect remained significant despite controlling for mean arterial pressure, but disappeared following adjustment for RAS blockade.

The 24-hour albuminuria was similar between the HDP and non-HDP groups.

The findings showed that HDPs did not increase the incidence of CKD, researchers said, adding that they were unable to identify a significant risk for kidney function decline after patient-reported HDP.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
12 Jun 2018
Percutaneous coronary intervention (PCI) is a safe procedure to perform on obese and morbidly obese patients, a recent study has shown.
Roshini Claire Anthony, 11 Jun 2018

Patients who received a combination of ticagrelor plus aspirin within 24 hours of undergoing coronary artery bypass grafting (CABG) had significantly improved saphenous vein graft patency rates 1 year post-procedure compared with those who only received aspirin, according to findings of the DACAB* trial.

4 days ago
Higher activity of plasma xanthine oxidase appears to be linked to insulin resistance and liver dysfunction among type 2 diabetes mellitus (T2DM) patients with metabolic syndrome (MetS), according to a recent Japan study.
4 days ago
Use of quetiapine among critically ill patients rarely leads to corrected QT (QTc) interval prolongation, reports a new study.